Michigan loses $3M on drug manufacturing try; API maker Croda buys a biotech firm;

> The University of Michigan expects to lose $120,000 next year, on top of $3.028 million this year, invested in an effort to get a Department of Defense contract to manufacture products at a former Pfizer ($PFE) site. Story

> A trade association in Africa says if countries there would invest more in research and development they would get better manufacturing as a side benefit. Article

> Chemicalmaker Croda has paid £5.9 million ($9.2 million) to buy the Italian biotech company Istituto di Ricerche Biotecnologiche and will merge it with its Sederma skin care business. Release

> Growth of 13% the unit that includes API sales at Albemarle helped buffer the overall 8% fall in revenue in the second quarter. Story

And Finally... The SME Pharma Industries Confederation (SPIC) in India is pushing the government even the tax burden for all contract manufacturing organizations, saying that those in tax-free zones are getting 70% of all contracts. Story

Webinar

Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how IPM.ai transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.